Elien Roose

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Highly Efficient

Monoclonal Antibody

Ejection Fraction

Top Venues

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Shannen J Deconinck, Christoph Nix, Svenja Barth, Eveline Bennek-Schöpping, Antoine Rauch, An-Sofie Schelpe, Elien Roose, Hendrik B Feys, Inge Pareyn, Aline Vandenbulcke, Joshua Muia, Christophe Vandenbriele, Sophie Susen, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon F De Meyer, Karen Vanhoorelbeke
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Kadri Kangro, Elien Roose, Charlotte Dekimpe, Aline Vandenbulcke, Nuno A G Graça, Jan Voorberg, Mart Ustav, Andres Männik, Karen Vanhoorelbeke
Improvement of recombinant ADAMTS13 production through a more optimal signal peptide or an N-terminal fusion protein. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Laure de Waele, Alexandre Curie, Kadri Kangro, Edwige Tellier, Gilles Kaplanski, Andres Männik, Claudia Tersteeg, Bérangère S Joly, Paul Coppo, Agnès Veyradier, Simon F De Meyer, Elien Roose, Karen Vanhoorelbeke
Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP. Blood advances 5 (21) (2021)
Kadri Kangro, Elien Roose, Bérangère S Joly, György Sinkovits, Tanja Falter, Charis von Auer, Heidi Rossmann, Marienn Reti, Jan Voorberg, Zoltán Prohászka, Bernhard Lämmle, Paul Coppo, Agnès Veyradier, Simon F De Meyer, Andres Männik, Karen Vanhoorelbeke
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura. Blood advances 5 (17) (2021)